Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
150 participants
OBSERVATIONAL
2024-07-22
2026-06-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The study is an observational research. Participants will be interviewed twice in total. All primary and secondary outcomes will be assessed at the first meeting. The second come will be performed within 5-7 days after the first assessment. In the second come, only the new kinesiophobia scale that is intended to be developed will be applied.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Development a New Scale for Assessment Shoulder Problems
NCT05391516
Is Gender a Factor in Patients With Subacromial Shoulder Pain?
NCT06758986
Effects of Scapular Exercise on Patients With Scapulocostal Syndrome
NCT02067598
Scapula and Upper Extremity Performance in Scoliosis
NCT07249515
Anterior Shoulder Dislocation at Emergency Department
NCT06531590
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Observational Group
All of the outcomes will be applied to patients who come to the outpatient clinic due to shoulder problems. Then, 1 week later, participants will be recalled to apply the multidimensional kinesiophobia scale a second time.
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Presence of traumatological, orthopedic and rheumatological pathology in the upper extremity
* Mini-Mental State Examination score \>24 points
Exclusion Criteria
* Psychiatric drug use,
* Use of painkillers during evaluation periods,
* Those who received physiotherapy before the study (last 6 months),
* Those whose education level is below secondary school level,
18 Years
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Emre Şenocak
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Emre Şenocak
Research Assistant
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Abdurrahman Tanhan, PhD
Role: STUDY_CHAIR
Bitlis Eren University
Zeynep Hoşbay, Associate Professor
Role: STUDY_CHAIR
Biruni University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Clinic of İstanbul Hand-Microsurgery Rehabilitation
Istanbul, , Turkey (Türkiye)
Clinic of İstanbul Hand-Microsurgery Rehabilitation
Istanbul, , Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2024/74
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.